# Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer

Source: https://onco.cc/trials/nct06017284/  
OnCo record `nct06017284` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of thalidomide, nab-paclitaxel and gemcitabine in pancreatic cancer, run by Fudan University, now recruiting.

## Summary

Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer is a phase 3, randomised interventional study registered as NCT06017284 by Fudan University, with a registry enrolment figure of 100 participants, started 2023-11-01 and due to reach its primary completion in 2025-11-30. Interventions recorded: Thalidomide; Nab paclitaxel; Gemcitabine; Placebo. Conditions listed: Pancreatic Cancer Stage IV; Chemotherapy-induced Nausea and Vomiting. Primary outcome: Rate of nausea/vomiting. Pancreatic eligibility wording from the registry: "* Histologically or cytologically confirmed metastatic pancreas adenocarcinoma". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Also known as: PTCA199-5
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT06017284
- Phase: 3
- Setting: Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer
- Sponsor: Fudan University
- Enrolled: 100

## Sources

- ClinicalTrials.gov NCT06017284: https://clinicaltrials.gov/study/NCT06017284

## Connected records

- cancers: [Metastatic pancreatic ductal adenocarcinoma](https://onco.cc/cancers/metastatic-pdac/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/)
- drugs: [Gemcitabine](https://onco.cc/drugs/gemcitabine/), [Nab-paclitaxel](https://onco.cc/drugs/nab-paclitaxel/), [Thalidomide](https://onco.cc/drugs/thalidomide/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06017284.json